[Table/Fig-3]:
Changes from baseline in the objective clinical measures after one month from using green tea.
| Variables | Green tea group | Control group | |||
|---|---|---|---|---|---|
| Baseline | One Month Later | Baseline | One Month Later | p-Value* | |
| Symptoms score (0 to 28) |
9±0.86 | -4.1±2.27 | 9.03±0.75 | -2.4±1.88 | 0.002 |
| Schirmer test score (mm) | 8.2±0.30 | 0.4±0.72 | 8.16±0.29 | 0.3±0.91 | 0.641 |
| Tear breakup time (s) | 6.1±0.23 | 3.03±1.29 | 6.3±0.25 | 1.03±0.80 | 0.001 |
| Corneal staining score (0 to 15) | 3.8±0.22 | -0.13±0.73 | 4.06±0.20 | +0.10±0.71 | 0.215 |
| Conjunctival staining score (0 to 18) | 8.06±0.24 | -0.16±0.69 | 7.56±0.25 | -0.43±0.81 | 0.180 |
| Meibum quality score (0 to 4) | 1.06±0.09 | -0.35±0.26 | 1.03±0.09 | -0.13±0.26 | 0.002 |
*The P-value is associated with comparing two groups of control and green tea one month later using green tea.